Clinical trial
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma…
NCT00025441 · Societe Internationale d'Oncologie Pediatrique, Other · Completed
Key facts
| NCT number | NCT00025441 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors |
| Official title | MMT 98 Study For Metastatic Disease Rhabdomyosarcoma And Other Malignant Soft Tissue Sarcoma Of Childhood |
| Lead sponsor | Societe Internationale d'Oncologie Pediatrique, Other |
| Collaborators | Children's Cancer and Leukaemia Group Societe Francaise Oncologie Pediatrique |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Sarcoma, Small Intestine Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | dactinomycin, filgrastim, carboplatin, cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, etoposide, ifosfamide, vincristine sulfate, peripheral blood stem cell transplantation and 1 more |
| Start date | Nov 1, 1998 |
| Completion | Mar 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 4, 2013 |
| Countries | France, Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: